PI
KNSA icon

Putnam Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Putnam Investments’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$693K Sell
39,486
-1,256
-3% -$20.6K ﹤0.01% 886
2023
Q3 		$708K Sell
40,742
-351
-0.9% -$5.91K ﹤0.01% 878
2023
Q2 		$579K Sell
41,093
-1,281
-3% -$17.1K ﹤0.01% 908
2023
Q1 		$456K Buy
42,374
+18,427
+77% +$243K ﹤0.01% 958
2022
Q4 		$359K Buy
+23,947
New +$349K ﹤0.01% 1029

Other funds holding KNSA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Putnam Investments's KNSA Position: Q4 2023 in Review

Putnam Investments reduced its Kiniksa Pharmaceuticals (KNSA) stake by 3.1% in Q4 2023, selling an estimated $20.6K and leaving 39,486 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Putnam Investments first reported a position in KNSA in Q4 2022 and has held it in 5 quarters since. The position peaked at $708K in Q3 2023. 142 funds tracked by Wall St. Rank hold KNSA as of Q4 2023.

  • Putnam Investments held 39,486 shares of Kiniksa Pharmaceuticals worth $693K as of Q4 2023.
  • Putnam Investments sold 1,256 Kiniksa Pharmaceuticals shares in Q4 2023, an estimated $20.6K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #886 holding.
  • Putnam Investments first reported a position in Kiniksa Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Putnam Investments's Kiniksa Pharmaceuticals position peaked at $708K in Q3 2023.
  • 142 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.